Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposom Forte with Citalopram in Elderly MDD
NCT04975724Phase 4Recruiting
- Sponsor
- Fidia Farmaceutici
- Start
- Apr 2019
- Primary completion
- Oct 2025
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of hypothalamic phospholipid liposomes in major depressive disorder (MDD), sponsored by Fidia Farmaceutici. Started Apr 2019; status: recruiting.
02
Drugs
hypothalamic phospholipid liposomes
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04975724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04975724.